
Novabay Pharmaceuticals Inc (NBY) receives a Buy rating from Ladenburg Thalmann
Novabay Pharmaceuticals Inc’s recently made public that its 10% Owner POPLAR POINT CAPITAL PARTNERS acquired Company’s shares for reported $12929.0
Novabay Pharmaceuticals Inc’s recently made public that its 10% Owner POPLAR POINT CAPITAL PARTNERS acquired Company’s shares for reported $12929.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Novabay Pharmaceuticals Inc revealed its 10% Owner POPLAR POINT CAPITAL PARTNERS acquired Company’s shares for reported $12929.0
Novabay Pharmaceuticals Inc’s recently made public that its 10% Owner POPLAR POINT CAPITAL PARTNERS acquired Company’s shares for reported $12929.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Novabay Pharmaceuticals
The NASDAQ gained 1.0% and the S&P 500 advanced 0.3% in yesterday’s trading session, while the blue chip Dow Jones